 | • レポートコード：QAF27563 • 出版社/出版日：QYResearch / 2021年3月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の抗体薬物複合体（ADC）市場について種類別（アドセトリス、カドサイラ）、用途別（乳がん、リンパ腫）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・抗体薬物複合体（ADC）市場の概要 ・世界の主要地域別抗体薬物複合体（ADC）市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の抗体薬物複合体（ADC）市場規模2016-2021：種類別（アドセトリス、カドサイラ） ・世界の抗体薬物複合体（ADC）市場予測2012-2027：種類別（アドセトリス、カドサイラ） ・世界の抗体薬物複合体（ADC）市場規模2016-2021：用途別（乳がん、リンパ腫） ・世界の抗体薬物複合体（ADC）市場予測2012-2027：用途別（乳がん、リンパ腫） ・抗体薬物複合体（ADC）のアメリカ市場規模と予測2016-2021 ・抗体薬物複合体（ADC）のヨーロッパ市場規模と予測2016-2021 ・抗体薬物複合体（ADC）の中国市場規模と予測2016-2021 ・抗体薬物複合体（ADC）の日本市場規模と予測2016-2021 ・抗体薬物複合体（ADC）の東南アジア市場規模と予測2016-2021 ・抗体薬物複合体（ADC）のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （ImmunoGen、Seattle Genetics、Roche、Takeda） ・抗体薬物複合体（ADC）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗体薬物複合体（ADC）の市場動向・機会・課題 ・調査の結論 |
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
North America ranks the top in terms of global market size of Antibody Drug Conjugate, it consists of 59.12% of the international market in 2016. Europe comes the second, with 27.70% of the global market. Asia Pacific consists of 6.54%of the Antibody Drug Conjugate market in the same year.
Market Analysis and Insights: Global Antibody-drug Conjugates Market
The global Antibody-drug Conjugates market was valued at US$ 2813.9 in 2020 and will reach US$ 3360 million by the end of 2027, growing at a CAGR of 3.0% during 2022-2027.
Global Antibody-drug Conjugates Scope and Market Size
The global Antibody-drug Conjugates market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antibody-drug Conjugates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Adcetris
Kadcyla
Segment by Application
Breast Cancer
Lymphoma
The Antibody-drug Conjugates market is analysed and market size information is provided by regions (countries). Segment by Application, the Antibody-drug Conjugates market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
ImmunoGen
Seattle Genetics
Roche
Takeda
1 Antibody-drug Conjugates Market Overview
1.1 Antibody-drug Conjugates Product Scope
1.2 Antibody-drug Conjugates Segment by Type
1.2.1 Global Antibody-drug Conjugates Sales by Type (2016 & 2021 & 2027)
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Antibody-drug Conjugates Segment by Application
1.3.1 Global Antibody-drug Conjugates Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Antibody-drug Conjugates Market Estimates and Forecasts (2016-2027)
1.4.1 Global Antibody-drug Conjugates Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Antibody-drug Conjugates Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Antibody-drug Conjugates Price Trends (2016-2027)
2 Antibody-drug Conjugates Estimates and Forecasts by Region
2.1 Global Antibody-drug Conjugates Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Antibody-drug Conjugates Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Antibody-drug Conjugates Sales Market Share by Region (2016-2021)
2.2.2 Global Antibody-drug Conjugates Revenue Market Share by Region (2016-2021)
2.3 Global Antibody-drug Conjugates Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Antibody-drug Conjugates Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Antibody-drug Conjugates Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Antibody-drug Conjugates Estimates and Projections (2016-2027)
2.4.2 Europe Antibody-drug Conjugates Estimates and Projections (2016-2027)
2.4.3 China Antibody-drug Conjugates Estimates and Projections (2016-2027)
2.4.4 Japan Antibody-drug Conjugates Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Antibody-drug Conjugates Estimates and Projections (2016-2027)
2.4.6 India Antibody-drug Conjugates Estimates and Projections (2016-2027)
3 Global Antibody-drug Conjugates Competition Landscape by Players
3.1 Global Top Antibody-drug Conjugates Players by Sales (2016-2021)
3.2 Global Top Antibody-drug Conjugates Players by Revenue (2016-2021)
3.3 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2020)
3.4 Global Antibody-drug Conjugates Average Price by Company (2016-2021)
3.5 Manufacturers Antibody-drug Conjugates Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Antibody-drug Conjugates Market Size by Type
4.1 Global Antibody-drug Conjugates Historic Market Review by Type (2016-2021)
4.1.1 Global Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
4.1.2 Global Antibody-drug Conjugates Revenue Market Share by Type (2016-2021)
4.1.3 Global Antibody-drug Conjugates Price by Type (2016-2021)
4.2 Global Antibody-drug Conjugates Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Antibody-drug Conjugates Sales Forecast by Type (2022-2027)
4.2.2 Global Antibody-drug Conjugates Revenue Forecast by Type (2022-2027)
4.2.3 Global Antibody-drug Conjugates Price Forecast by Type (2022-2027)
5 Global Antibody-drug Conjugates Market Size by Application
5.1 Global Antibody-drug Conjugates Historic Market Review by Application (2016-2021)
5.1.1 Global Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
5.1.2 Global Antibody-drug Conjugates Revenue Market Share by Application (2016-2021)
5.1.3 Global Antibody-drug Conjugates Price by Application (2016-2021)
5.2 Global Antibody-drug Conjugates Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Antibody-drug Conjugates Sales Forecast by Application (2022-2027)
5.2.2 Global Antibody-drug Conjugates Revenue Forecast by Application (2022-2027)
5.2.3 Global Antibody-drug Conjugates Price Forecast by Application (2022-2027)
6 North America Antibody-drug Conjugates Market Facts & Figures
6.1 North America Antibody-drug Conjugates Sales by Company
6.1.1 North America Antibody-drug Conjugates Sales by Company (2016-2021)
6.1.2 North America Antibody-drug Conjugates Revenue by Company (2016-2021)
6.2 North America Antibody-drug Conjugates Sales Breakdown by Type
6.2.1 North America Antibody-drug Conjugates Sales Breakdown by Type (2016-2021)
6.2.2 North America Antibody-drug Conjugates Sales Breakdown by Type (2022-2027)
6.3 North America Antibody-drug Conjugates Sales Breakdown by Application
6.3.1 North America Antibody-drug Conjugates Sales Breakdown by Application (2016-2021)
6.3.2 North America Antibody-drug Conjugates Sales Breakdown by Application (2022-2027)
7 Europe Antibody-drug Conjugates Market Facts & Figures
7.1 Europe Antibody-drug Conjugates Sales by Company
7.1.1 Europe Antibody-drug Conjugates Sales by Company (2016-2021)
7.1.2 Europe Antibody-drug Conjugates Revenue by Company (2016-2021)
7.2 Europe Antibody-drug Conjugates Sales Breakdown by Type
7.2.1 Europe Antibody-drug Conjugates Sales Breakdown by Type (2016-2021)
7.2.2 Europe Antibody-drug Conjugates Sales Breakdown by Type (2022-2027)
7.3 Europe Antibody-drug Conjugates Sales Breakdown by Application
7.3.1 Europe 131 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 131 Sales Breakdown by Application (2022-2027)
8 China Antibody-drug Conjugates Market Facts & Figures
8.1 China Antibody-drug Conjugates Sales by Company
8.1.1 China Antibody-drug Conjugates Sales by Company (2016-2021)
8.1.2 China Antibody-drug Conjugates Revenue by Company (2016-2021)
8.2 China Antibody-drug Conjugates Sales Breakdown by Type
8.2.1 China Antibody-drug Conjugates Sales Breakdown by Type (2016-2021)
8.2.2 China Antibody-drug Conjugates Sales Breakdown by Type (2022-2027)
8.3 China Antibody-drug Conjugates Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)
9 Japan Antibody-drug Conjugates Market Facts & Figures
9.1 Japan Antibody-drug Conjugates Sales by Company
9.1.1 Japan Antibody-drug Conjugates Sales by Company (2016-2021)
9.1.2 Japan Antibody-drug Conjugates Revenue by Company (2016-2021)
9.2 Japan Antibody-drug Conjugates Sales Breakdown by Type
9.2.1 Japan Antibody-drug Conjugates Sales Breakdown by Type (2016-2021)
9.2.2 Japan Antibody-drug Conjugates Sales Breakdown by Type (2022-2027)
9.3 Japan Antibody-drug Conjugates Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Antibody-drug Conjugates Market Facts & Figures
10.1 Southeast Asia Antibody-drug Conjugates Sales by Company
10.1.1 Southeast Asia Antibody-drug Conjugates Sales by Company (2016-2021)
10.1.2 Southeast Asia Antibody-drug Conjugates Revenue by Company (2016-2021)
10.2 Southeast Asia Antibody-drug Conjugates Sales Breakdown by Type
10.2.1 Southeast Asia Antibody-drug Conjugates Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Antibody-drug Conjugates Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Antibody-drug Conjugates Sales Breakdown by Application
10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)
11 India Antibody-drug Conjugates Market Facts & Figures
11.1 India Antibody-drug Conjugates Sales by Company
11.1.1 India Antibody-drug Conjugates Sales by Company (2016-2021)
11.1.2 India Antibody-drug Conjugates Revenue by Company (2016-2021)
11.2 India Antibody-drug Conjugates Sales Breakdown by Type
11.2.1 India Antibody-drug Conjugates Sales Breakdown by Type (2016-2021)
11.2.2 India Antibody-drug Conjugates Sales Breakdown by Type (2022-2027)
11.3 India Antibody-drug Conjugates Sales Breakdown by Application
11.3.1 India Antibody-drug Conjugates Sales Breakdown by Application (2016-2021)
11.3.2 India Antibody-drug Conjugates Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Antibody-drug Conjugates Business
12.1 ImmunoGen
12.1.1 ImmunoGen Corporation Information
12.1.2 ImmunoGen Business Overview
12.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.1.4 ImmunoGen Antibody-drug Conjugates Products Offered
12.1.5 ImmunoGen Recent Development
12.2 Seattle Genetics
12.2.1 Seattle Genetics Corporation Information
12.2.2 Seattle Genetics Business Overview
12.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Seattle Genetics Antibody-drug Conjugates Products Offered
12.2.5 Seattle Genetics Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Business Overview
12.3.3 Roche Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Roche Antibody-drug Conjugates Products Offered
12.3.5 Roche Recent Development
12.4 Takeda
12.4.1 Takeda Corporation Information
12.4.2 Takeda Business Overview
12.4.3 Takeda Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Takeda Antibody-drug Conjugates Products Offered
12.4.5 Takeda Recent Development
…
13 Antibody-drug Conjugates Manufacturing Cost Analysis
13.1 Antibody-drug Conjugates Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antibody-drug Conjugates
13.4 Antibody-drug Conjugates Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antibody-drug Conjugates Distributors List
14.3 Antibody-drug Conjugates Customers
15 Market Dynamics
15.1 Antibody-drug Conjugates Market Trends
15.2 Antibody-drug Conjugates Drivers
15.3 Antibody-drug Conjugates Market Challenges
15.4 Antibody-drug Conjugates Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Antibody-drug Conjugates Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Antibody-drug Conjugates Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Antibody-drug Conjugates Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Antibody-drug Conjugates Sales (Kg) by Region (2016-2021)
Table 5. Global Antibody-drug Conjugates Sales Market Share by Region (2016-2021)
Table 6. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Antibody-drug Conjugates Revenue Share by Region (2016-2021)
Table 8. Global Antibody-drug Conjugates Sales (Kg) Forecast by Region (2022-2027)
Table 9. Global Antibody-drug Conjugates Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Antibody-drug Conjugates Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Antibody-drug Conjugates Revenue Share Forecast by Region (2022-2027)
Table 12. Global Antibody-drug Conjugates Sales (Kg) of Key Companies (2016-2021)
Table 13. Global Antibody-drug Conjugates Sales Share by Company (2016-2021)
Table 14. Global Antibody-drug Conjugates Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Antibody-drug Conjugates Revenue Share by Company (2016-2021)
Table 16. Global Antibody-drug Conjugates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugates as of 2020)
Table 17. Global Antibody-drug Conjugates Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Antibody-drug Conjugates Manufacturing Sites and Area Served
Table 19. Manufacturers Antibody-drug Conjugates Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Antibody-drug Conjugates Sales (Kg) by Type (2016-2021)
Table 22. Global Antibody-drug Conjugates Sales Share by Type (2016-2021)
Table 23. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Antibody-drug Conjugates Price (USD/Kg) by Type (2016-2021)
Table 25. Global Antibody-drug Conjugates Sales Share by Type (2022-2027)
Table 26. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Antibody-drug Conjugates Revenue Share by Type (2022-2027)
Table 28. Global Antibody-drug Conjugates Price (USD/Kg) by Type (2022-2027)
Table 29. Global Antibody-drug Conjugates Sales (Kg) by Application (2016-2021)
Table 30. Global Antibody-drug Conjugates Sales Share by Application (2016-2021)
Table 31. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Antibody-drug Conjugates Price (USD/Kg) by Application (2016-2021)
Table 33. Global Antibody-drug Conjugates Sales (Kg) by Application (2022-2027)
Table 34. Global Antibody-drug Conjugates Sales Share by Application (2022-2027)
Table 35. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Antibody-drug Conjugates Revenue Share by Application (2022-2027)
Table 37. Global Antibody-drug Conjugates Price (USD/Kg) by Application (2022-2027)
Table 38. North America Antibody-drug Conjugates Sales (Kg) by Company (2016-2021)
Table 39. North America Antibody-drug Conjugates Sales Market Share by Company (2016-2021)
Table 40. North America Antibody-drug Conjugates Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Antibody-drug Conjugates Revenue Market Share by Company (2016-2021)
Table 42. North America Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 43. North America Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
Table 44. North America Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg)
Table 45. North America Antibody-drug Conjugates Sales Market Share by Type (2022-2027)
Table 46. North America Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 47. North America Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
Table 48. North America Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg)
Table 49. North America Antibody-drug Conjugates Sales Market Share by Application (2022-2027)
Table 50. Europe Antibody-drug Conjugates Sales (Kg) by Company (2016-2021)
Table 51. Europe Antibody-drug Conjugates Sales Market Share by Company (2016-2021)
Table 52. Europe Antibody-drug Conjugates Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Antibody-drug Conjugates Revenue Market Share by Company (2016-2021)
Table 54. Europe Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 55. Europe Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
Table 56. Europe Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg)
Table 57. Europe Antibody-drug Conjugates Sales Market Share by Type (2022-2027)
Table 58. Europe Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 59. Europe Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
Table 60. Europe Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg)
Table 61. Europe Antibody-drug Conjugates Sales Market Share by Application (2022-2027)
Table 62. China Antibody-drug Conjugates Sales (Kg) by Company (2016-2021)
Table 63. China Antibody-drug Conjugates Sales Market Share by Company (2016-2021)
Table 64. China Antibody-drug Conjugates Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Antibody-drug Conjugates Revenue Market Share by Company (2016-2021)
Table 66. China Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 67. China Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
Table 68. China Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg)
Table 69. China Antibody-drug Conjugates Sales Market Share by Type (2022-2027)
Table 70. China Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 71. China Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
Table 72. China Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg)
Table 73. China Antibody-drug Conjugates Sales Market Share by Application (2022-2027)
Table 74. Japan Antibody-drug Conjugates Sales (Kg) by Company (2016-2021)
Table 75. Japan Antibody-drug Conjugates Sales Market Share by Company (2016-2021)
Table 76. Japan Antibody-drug Conjugates Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Antibody-drug Conjugates Revenue Market Share by Company (2016-2021)
Table 78. Japan Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 79. Japan Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
Table 80. Japan Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg)
Table 81. Japan Antibody-drug Conjugates Sales Market Share by Type (2022-2027)
Table 82. Japan Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 83. Japan Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
Table 84. Japan Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg)
Table 85. Japan Antibody-drug Conjugates Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Antibody-drug Conjugates Sales (Kg) by Company (2016-2021)
Table 87. Southeast Asia Antibody-drug Conjugates Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Antibody-drug Conjugates Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Antibody-drug Conjugates Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 91. Southeast Asia Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg)
Table 93. Southeast Asia Antibody-drug Conjugates Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 95. Southeast Asia Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg)
Table 97. Southeast Asia Antibody-drug Conjugates Sales Market Share by Application (2022-2027)
Table 98. India Antibody-drug Conjugates Sales (Kg) by Company (2016-2021)
Table 99. India Antibody-drug Conjugates Sales Market Share by Company (2016-2021)
Table 100. India Antibody-drug Conjugates Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Antibody-drug Conjugates Revenue Market Share by Company (2016-2021)
Table 102. India Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg)
Table 103. India Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
Table 104. India Antibody-drug Conjugates Sales by Type (2022-2027) & (Kg)
Table 105. India Antibody-drug Conjugates Sales Market Share by Type (2022-2027)
Table 106. India Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg)
Table 107. India Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
Table 108. India Antibody-drug Conjugates Sales by Application (2022-2027) & (Kg)
Table 109. India Antibody-drug Conjugates Sales Market Share by Application (2022-2027)
Table 110. ImmunoGen Corporation Information
Table 111. ImmunoGen Description and Business Overview
Table 112. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. ImmunoGen Antibody-drug Conjugates Product
Table 114. ImmunoGen Recent Development
Table 115. Seattle Genetics Corporation Information
Table 116. Seattle Genetics Description and Business Overview
Table 117. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Seattle Genetics Antibody-drug Conjugates Product
Table 119. Seattle Genetics Recent Development
Table 120. Roche Corporation Information
Table 121. Roche Description and Business Overview
Table 122. Roche Antibody-drug Conjugates Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Roche Antibody-drug Conjugates Product
Table 124. Roche Recent Development
Table 125. Takeda Corporation Information
Table 126. Takeda Description and Business Overview
Table 127. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Takeda Antibody-drug Conjugates Product
Table 129. Takeda Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Antibody-drug Conjugates Distributors List
Table 133. Antibody-drug Conjugates Customers List
Table 134. Antibody-drug Conjugates Market Trends
Table 135. Antibody-drug Conjugates Market Drivers
Table 136. Antibody-drug Conjugates Market Challenges
Table 137. Antibody-drug Conjugates Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody-drug Conjugates Product Picture
Figure 2. Global Antibody-drug Conjugates Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Antibody-drug Conjugates Sales Market Share by Application in 2021 & 2027
Figure 6. Breast Cancer Examples
Figure 7. Lymphoma Examples
Figure 8. Global Antibody-drug Conjugates Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Antibody-drug Conjugates Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Antibody-drug Conjugates Sales (Kg) Growth Rate (2016-2027)
Figure 11. Global Antibody-drug Conjugates Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 12. Global Antibody-drug Conjugates Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Antibody-drug Conjugates Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Antibody-drug Conjugates Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Antibody-drug Conjugates Sales (Kg) Growth Rate (2016-2027)
Figure 16. Europe Antibody-drug Conjugates Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Antibody-drug Conjugates Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Antibody-drug Conjugates Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Antibody-drug Conjugates Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Antibody-drug Conjugates Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Antibody-drug Conjugates Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Antibody-drug Conjugates Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Antibody-drug Conjugates Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Antibody-drug Conjugates Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Antibody-drug Conjugates Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Antibody-drug Conjugates Players Market Share by Revenue in Antibody-drug Conjugates: 2016 & 2020
Figure 27. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Antibody-drug Conjugates Revenue Share by Type (2016-2021)
Figure 29. Global Antibody-drug Conjugates Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Antibody-drug Conjugates Revenue Share by Application (2016-2021)
Figure 31. Global Antibody-drug Conjugates Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Antibody-drug Conjugates Sales Market Share by Type in 2020
Figure 33. North America Antibody-drug Conjugates Sales Market Share by Application in 2020
Figure 34. Europe Antibody-drug Conjugates Sales Market Share by Type in 2020
Figure 35. Europe Antibody-drug Conjugates Sales Market Share by Application in 2020
Figure 36. China Antibody-drug Conjugates Sales Market Share by Type in 2020
Figure 37. China Antibody-drug Conjugates Sales Market Share by Application in 2020
Figure 38. Japan Antibody-drug Conjugates Sales Market Share by Type in 2020
Figure 39. Japan Antibody-drug Conjugates Sales Market Share by Application in 2020
Figure 40. Southeast Asia Antibody-drug Conjugates Sales Market Share by Type in 2020
Figure 41. Southeast Asia Antibody-drug Conjugates Sales Market Share by Application in 2020
Figure 42. India Antibody-drug Conjugates Sales Market Share by Type in 2020
Figure 43. India Antibody-drug Conjugates Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Antibody-drug Conjugates
Figure 46. Manufacturing Process Analysis of Antibody-drug Conjugates
Figure 47. Antibody-drug Conjugates Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
ポリマー薬物コンジュゲートのグローバル市場調査 2019年 The global Polymer Drug Conjugates market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polymer Drug Conjugates volume and value at global level, regional level and company level. From a global perspecti…- ポリマー薬物コンジュゲートのグローバル市場調査 2019年 The global Polymer Drug Conjugates market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polymer Drug Conjugates volume and value at global level, regional level and company level. From a global perspecti…
- 世界の抗ニューロフィラメントL抗体市場規模・現状・予測（2021年-2027年） Neurofilament is a type of filament that is required for the cytoskeleton of a neuron that supports the axon cytoplasm. The neurofilaments are the most common types of fibrillar component s that are available in the axon. Market Analysis and Insights: Global Anti Neurofilament L Antibody Market The …
- 世界のウサギ抽出抗DPH5抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-DPH5 Antibody Produced In Rabbit Market The global Anti-DPH5 Antibody Produced In Rabbit market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
- 世界の抗核抗体（ANA）検査市場規模・現状・予測（2021年-2027年） Antinuclear antibodies (ANA) are a group of autoantibodies produced by a person's immune system when it fails to adequately distinguish between "self" and "nonself." The ANA testing detects these autoantibodies in the blood. Market Analysis and Insights: Global Anti-nuclear Antibody (ANA) Testing Ma…